Toronto's $25 million commercialization 'engine' celebrates the appointment of its Board of Directors

    TORONTO, Feb. 6 /CNW/ - MaRS Innovation is honoured to announce its
permanent Board of Directors, who brings together a remarkable and broad set
of experiences and networks to support the development of this dynamic
partnership of Toronto research institutions. Designed to enhance the
commercial output of Toronto's world-leading research cluster, MaRS Innovation
is positioned to make a significant contribution to Canada's innovation
economy and the quality of life for Canadians and others around the world.
    Supported by the Government of Canada through the Centres of Excellence
in Research and Commercialization (CECR) program, and its member institutions,
MaRS Innovation is focused on converting important discoveries into a new
generation of products, services and high value jobs. The newly appointed
Board of Directors, which includes academic and business leaders from across
Canada and the United States, has the targeted expertise to guide MaRS
Innovation to deliver on this critical mission.
    MaRS Innovation represents a unique collaborative model, which aggregates
the exceptional discovery pipeline of 14 leading Toronto academic institutions
to build a diversified portfolio of assets, and harness the economic and job
creation potential of the best opportunities for Toronto, Ontario and Canada.
    "MaRS Innovation is privileged to announce a Board of Directors of this
caliber and breadth of skill," said Mary Jo Haddad, Chair of the MaRS
Innovation Board and President and CEO of The Hospital for Sick Children. "The
collective experience and guidance of these individuals will be critical to
developing a collaborative, integrated and agile approach to this
transformational organization that will move Canada into its next phase of
economic development."

    The newly appointed members are:

    -   W. Geoffrey Beattie - Deputy Chairman & President, Woodbridge Company
        Limited, Thomson Reuters Corporation, Toronto
    -   Christopher C. Capelli - Vice President, Technology Based Ventures,
        Office of Technology Commercialization, University of Texas, M.D.
        Anderson Cancer Center, Houston, TX
    -   Ron Close - Information technology entrepreneur, Entrepreneur-in-
        Residence, MaRS, and Executive Entrepreneur-in-Residence, The Richard
        Ivey School of Business, The University of Western Ontario, London,
    -   Nicholas Darby - Formerly Director of Physical Sciences, Corporate
        Venture Capital, Dow Chemical Company, President, Darby & Associates
        Consulting LLC, Midland, MI
    -   Mary Jo Haddad - President & CEO, The Hospital for Sick Children,
    -   Jacqueline H.R. Le Saux - Former General Counsel, North America and
        Corporate Secretary, Patheon, Inc., Toronto
    -   David A. Leslie - Chair, Sunnybrook Health Sciences Centre, and
        Former Chairman & CEO, Ernst & Young, Toronto
    -   Michael H. May - President & CEO, Rimon Therapeutics, Toronto
    -   Chandra J. Panchal - Founder, President & CEO, Axcelon Biopolymers
        Corp., Dollard-des-Ormeaux, QC
    -   Ilse Treurnicht - CEO, MaRS Discovery District, Toronto
    -   Donald A. Wright - President & CEO, The Winnington Capital Group
        Inc., Toronto

    "I would like to extend a heartfelt thank you to the founding board
members for their outstanding commitment in creating the integrated
commercialization platform - which is MaRS Innovation," said Founding Chair
Mary Jo Haddad, President and CEO, The Hospital for Sick Children. The other
members of the founding Board of Directors were Robert Bell (President and
CEO, University Health Network), Tim McTiernan (Assistant Vice President,
University of Toronto), Sheldon Levy (President, Ryerson University), David
Leslie (Chair, Sunnybrook Health Sciences Centre), John Evans (Chair, MaRS
Discovery District) and Ilse Treurnicht (CEO, MaRS).
    MaRS Innovation serves as a business accelerator platform with a single
point of entry for industry partners and investors. It will increase the
scale, scope and viability of IP offerings, and the quantity and quality of
deal flow from partner institutions. MaRS Innovation will also facilitate
strategic research collaborations with industry partners, strengthen the
innovation capacity of Canadian industry through adoption of new technologies
from its member institutions, and launch a new generation of robust,
high-growth Canadian companies that will become global market leaders. The
quality of the combined discovery pipeline will catalyze and attract sources
of risk capital for translational research, market validation, company
formation and growth.
    "MaRS Innovation represents a unique and timely platform to contribute in
a meaningful way to Canada's knowledge economy, leveraging Toronto's
remarkable research excellence. The vision and serious commitment of its
members to work together to transform our commercialization results, and the
support of the Federal Government, made this possible. The announcement of
this outstanding group of leaders to the Board of Directors for MaRS
Innovation is an exciting step forward," said Ilse Treurnicht, MaRS CEO and
interim Managing Director of MaRS Innovation.

    MaRS Innovation member organizations are:

    -   Baycrest Geriatric Health Care System
    -   BioDiscovery Toronto
    -   Bloorview Kids Rehab
    -   Centre for Addiction and Mental Health
    -   The Hospital for Sick Children
    -   MaRS Discovery District
    -   Mount Sinai Hospital
    -   The New Women's College Hospital
    -   Ontario College of Art and Design
    -   Ontario Institute for Cancer Research
    -   Ryerson University
    -   St. Michael's Hospital
    -   Sunnybrook Health Sciences Centre
    -   Toronto Rehabilitation Institute
    -   University Health Network
    -   University of Toronto

For further information:

For further information: Susan McGovern, Vice President, MaRS
Innovation, at or (647) 260-7878

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890